| General Information of Drug Metabolite (DM) (ID: DM005762) |
| DM Name |
N-[3-(N,NDiethylamino)propyl]-N-phenyl-2-aminoindan-5-ol
|
| PubChem CID |
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
DME0009
|
| Oxidation - Aromatic hydroxylation |
AC-1802
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| AC-1802 |
DR0126
|
Phase 1 |
Cardiac arrhythmia |
|
|
| References |
| 1 |
Cytochrome P450 inactivation by pharmaceuticals and phytochemicals: therapeutic relevance Drug Metab Rev. 2008;40(1):101-47. doi: 10.1080/03602530701836704.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
